Science Biodesix Faces Downgrade as Analysts Adjust Ratings and Targets Biodesix (NASDAQ:BDSX) has been downgraded to a “sell” rating by analysts at Wall Street Zen in a recent research report. This change, announced on... Editorial15 September, 2025